These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5155888)

  • 21. Benign pancreatic hyperenzymemia or Gullo's syndrome.
    Gullo L; Lucrezio L; Migliori M; Bassi M; Nesticò V; Costa PL
    Adv Med Sci; 2008; 53(1):1-5. PubMed ID: 18650145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hydrolysis of fatty acids esters by Mycobacterium phlei].
    Andrejew A; Desbordes J
    Ann Inst Pasteur (Paris); 1969 Oct; 117(4):486-500. PubMed ID: 5367503
    [No Abstract]   [Full Text] [Related]  

  • 23. [Methodology and clinical significance of a new pancreatic lipase test with di-dodecanoic acid ester of fluoresceine].
    Kaffarnik H; Meyer-Bertenrath JG
    Klin Wochenschr; 1969 Feb; 47(4):221-3. PubMed ID: 5369572
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical application of a new pancreatic lipase test].
    Kaffarnik H; Meyer-Bertenrath JG
    Verh Dtsch Ges Inn Med; 1968; 74():237-8. PubMed ID: 5714331
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of differential inhibition of hepatic and pancreatic fatty acid ethyl ester synthase by inhibitors of serine-esterases: in vitro and cell culture studies.
    Kaphalia BS; Mericle KA; Ansari GA
    Toxicol Appl Pharmacol; 2004 Oct; 200(1):7-15. PubMed ID: 15451303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic renin-angiotensin system: a novel target for the potential treatment of pancreatic diseases?
    Leung PS
    JOP; 2003 Mar; 4(2):89-91. PubMed ID: 12629265
    [No Abstract]   [Full Text] [Related]  

  • 27. [Should pancreatic lipase dethrone amylase as a pancreatic marker?].
    Sela BA; Doolman R
    Harefuah; 1995 May; 128(9):573-8. PubMed ID: 7541013
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serum lipase determination within the scope of pancreas diagnosis].
    Burkhardt G; Gabsch HC; Lantsch H
    Z Gesamte Inn Med; 1967 Feb; 22(4):112-7. PubMed ID: 5586039
    [No Abstract]   [Full Text] [Related]  

  • 29. [Benign pancreatic hyperenzynemia or Gullo's syndrome].
    Gullo L; Lucrezio L; Bassi M; Nesticò V; Migliori M
    Recenti Prog Med; 2008; 99(7-8):367-71. PubMed ID: 18751616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic digestive function after subtotal gastrectomy--evaluation by an indirect method.
    Malfertheiner P; Junge U; Ditschuneit H
    Hepatogastroenterology; 1984 Aug; 31(4):172-5. PubMed ID: 6479838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of secretin and prostigmine stimulation in functional pancreatic exploration].
    Ribera MT; Martinez-Brey M; Salvador R
    Rev Esp Enferm Apar Dig; 1968 Dec; 27(10):1435-42. PubMed ID: 5746861
    [No Abstract]   [Full Text] [Related]  

  • 32. Can pancreatic steatosis explain the finding of pancreatic hyperenzymemia in subjects with dyslipidemia?
    Gullo L; Salizzoni E; Serra C; Calculli L; Bastagli L; Migliori M
    Pancreas; 2006 Nov; 33(4):351-3. PubMed ID: 17079938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of pancreatic function. Simplified screening with fluorescein dilaurate using serum concentration determinations].
    Laggner A; Bastian L; Prager J; Pointner H; Deutsch E
    Fortschr Med; 1981 Apr; 99(16):589-91. PubMed ID: 7227951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problems in the determination of pancreatic enzymes for the quantitative functional diagnosis of the pancreas in children].
    Senger H; Beyreiss K; Scheerschmidt G; Dettmer D; Müller F
    Dtsch Z Verdau Stoffwechselkr; 1981; 41(2):70-82. PubMed ID: 6165543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma.
    Loor R; Kuriyama M; Bodziak ML; Inaji H; Douglass HO; Berjian R; Nicolai JJ; Tytgat GN; Chu TM
    Cancer Res; 1984 Aug; 44(8):3604-7. PubMed ID: 6744282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The two stage provocative test for pancreatic disease by serum enzyme measurements.
    Kim DK; Schwartz MK; Sherlock P
    Surg Gynecol Obstet; 1980 Jan; 150(1):49-53. PubMed ID: 7350701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal elastase test: evaluation of a new noninvasive pancreatic function test.
    Domínguez-Muñoz JE; Hieronymus C; Sauerbruch T; Malfertheiner P
    Am J Gastroenterol; 1995 Oct; 90(10):1834-7. PubMed ID: 7572904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclomaltoheptaose mixed esters of anti-inflammatory drugs and short-chain fatty acids and study of their enzymatic hydrolysis in vitro.
    Cao F; Ren Y; Hua W
    Carbohydr Res; 2009 Mar; 344(4):526-30. PubMed ID: 19185291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pancreatic maldigestion and malabsorption].
    Fric P
    Cesk Gastroenterol Vyz; 1983 Mar; 37(2):109-15. PubMed ID: 6342821
    [No Abstract]   [Full Text] [Related]  

  • 40. [Our experience with Neoeserine (Isis) in pancreatic function tests].
    Kaczmareck H
    Z Arztl Fortbild (Jena); 1967 Feb; 61(3):129-34. PubMed ID: 5586015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.